Lv3
272 积分 2022-08-04 加入
Generating functionally stable and antigen-specific T(reg) cells from effector T cells for cell therapy of inflammatory diseases
19小时前
已完结
CDK8/CDK19 inhibition restores T-cell homeostasis in primary immune thrombocytopenia
19小时前
已完结
Conversion of antigen-specific effector/memory T cells into Foxp3-expressing T(reg) cells by inhibition of CDK8/19
19小时前
已完结
A novel CDK8/19 inhibitor RO8323 mitigates allograft rejection through dual mechanisms of action to modulate regulatory T cell and myeloid cell
19小时前
已完结
Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer
5天前
已完结
The butterfly effect in cancer: a single base mutation can remodel the cell
6天前
已完结
Addition of Fluorine and a Late-Stage Functionalization (LSF) of the Oral SERD AZD9833
8天前
已完结
Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist
8天前
已完结
Optimization of a Novel Binding Motif to (E)-3-(3,5-Difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)phenyl)acrylic Acid (AZD9496), a Potent and Orally Bioavailable Selective Estrogen Receptor Downregulator and Antagonist
8天前
已完结
A patent review of mutant-selective PI3Kα inhibitors for the treatment of different cancers (2021–2025)
11天前
已完结
皖公网安备34019202002308
